Raja Rajalingam

Prof. Dr. Raja Rajalingam


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ZCZinal S. Chheda
Zinal S. Chheda
Gary KohanbashGary Kohanbash
Gary Kohanbash
KOKaori Okada
Kaori Okada
NJNaznin Jahan
Naznin Jahan
JSJohn Sidney
John Sidney
HOHideho Okada
Hideho Okada
The median overall survival for children with diffuse intrinsic pontine glioma (DIPG) is less than one year. The majority of diffuse midline gliomas, including more than 70% of DIPGs, harbor an amino acid substitution from lysine (K) to methionine (M) at position 27 of histone 3 variant 3 (H3.3). From a CD8+ T cell clone established by stimulation of HLA-A2+ CD8+ T cells with synthetic peptide encompassing the H3.3K27M mutation, complementary DNA for T cell receptor (TCR) α- and β-chains were cloned into a retroviral vector. TCR-transduced HLA-A2+ T cells efficiently killed HLA-A2+H3.3K27M+ glioma cells in an antigen- and HLA-specific manner. Adoptive transfer of TCR-transduced T cells significantly suppressed the progression of glioma xenografts in mice. Alanine-scanning assays suggested the absence of known human proteins sharing the key amino acid residues required for recognition by the TCR, suggesting that the TCR could be safely used in patients. These data provide us with a strong basis for developing T cell–based therapy targeting this shared neoepitope.

14 November 2006 in Immunogenetics
Verified
Journal Article
Closed access
PDF file
ZDZeying Du
Zeying Du
DGDavid W. Gjertson
David W. Gjertson
ERElaine F. Reed
Elaine F. Reed
RRRaja Rajalingam
Raja Rajalingam

28 March 2008 in Immunogenetics
Verified
Journal Article
Closed access
PDF file
RRRaja Rajalingam
Raja Rajalingam
ZDZeying Du
Zeying Du
AMAshley Meenagh
Ashley Meenagh
LLLihui Luo
Lihui Luo
VKValampuri John Kavitha
Valampuri John Kavitha
DMDerek Middleton
Derek Middleton

1 January 2011 in The Korean Journal of Hematology
Verified
Journal Article
Open access
PDF file
RRRaja Rajalingam
Raja Rajalingam
Rajalingam R. Korean J Hematol. 2011 Dec;46(4):216-228. http://dx.doi.org/10.5045/kjh.2011.46.4.216


12 June 2009 in Immunogenetics
Verified
Journal Article
Open access
PDF file
EAElham Ashouri
Elham Ashouri
SFShirin Farjadian
Shirin Farjadian
ERElaine F. Reed
Elaine F. Reed
AGAbbas Ghaderi
Abbas Ghaderi
RRRaja Rajalingam
Raja Rajalingam
Killer cell immunoglobulin-like receptors (KIR) regulate natural killer cell response against infection and malignancy. KIR genes are variable in the number and type, thereby discriminating individuals and populations. Herein, we analyzed the KIR gene content diversity in four native populations of Iran. The KIR genomic diversity was comparable between Bakhtiari and Persian and displayed a balance of A and B KIR haplotypes, a trend reported in Caucasian and African populations. The KIR gene content profiles of Arab and Azeri were comparable and displayed a preponderance of B haplotypes, a scenario reported in the natives of America, India, and Australia. A majority of the B haplotype carriers of Azeri and Arab had a centromeric gene-cluster (KIR2DS2-2DL2-2DS3-2DL5). Remarkably, this cluster was totally absent from the American natives but occurred at highest frequencies in the natives of India and Australia in combination with another gene cluster at the telomeric region (KIR3DS1-2DL5-2DS5-2DS1). Therefore, despite having similar frequencies of B haplotypes, the occurrence of B haplotype-specific KIR genes, such as 2DL2, 2DL5, 3DS1, 2DS1, 2DS2, 2DS3, and 2DS5 in Azeri and Arab were substantially different from the natives of America, India, and Australia. In conclusion, each Iranian population exhibits distinct KIR gene content diversity, and the Indo-European KIR genetic signatures of the Iranians concur with geographic proximity, linguistic affinity, and human migrations.